Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Kester Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$2M
Portfolio companies 8
Rounds per year 0.60
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.11
Exits 3
Key employees 4

Areas of investment

  • Medical Device
  • Pharmaceutical
  • Biopharma
  • Health Care
  • Software
Summary

Kester Capital appeared to be the VC, which was created in 2007. The fund was located in Europe if to be more exact in United Kingdom. The main office of represented VC is situated in the London.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Kester Capital, startups are often financed by The Still River Fund, HealthCare Ventures, Yasuda Enterprise Development. The meaningful sponsors for the fund in investment in the same round are Yasuda Enterprise Development, The Still River Fund, Neomed Management. In the next rounds fund is usually obtained by GTCR, Fosun Group.

Among the most popular portfolio startups of the fund, we may highlight Xanthus Pharmaceuticals. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical Device, Association. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

Besides them, we counted 4 critical employees of this fund in our database.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2006. The fund is constantly included in less than 2 investment rounds annually. Considering the real fund results, this VC is 66 percentage points more often commits exit comparing to other organizations. This Kester Capital works on 28 percentage points more the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2008.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Kester Capital:
Typical Co-investors
Kester Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Kester Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Capria Ventures Seattle, United States, Washington
Fibrotic Ventures Atlanta, Georgia, United States
Frazier Technology Ventures Seattle, United States, Washington
Garuda Ventures California, San Francisco, United States
Geo-Jade Petroleum Beijing, Beijing, China
Haiheng capital -
IdeaEdge Ventures California, San Diego, United States
Nirvana Venture Advisors India, Maharashtra, Mumbai
S-Kap Unternehmensbeteiligungs Baden-Wurttemberg, Germany, Pforzheim
Shanghai Decun Touzi Youxian Gongsi China, Shanghai
SORACOM Japan, Tokyo
Taaleri Finland, Helsinki, Southern Finland
TechFounders Bayern, Germany, Munich
Tickets.com California, Costa Mesa, United States
Toyota Tunas -
Zhanrui Xinfu Equity Investment Fund Management China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Xanthus Pharmaceuticals

Biopharma
Biotechnology
Medical
Pharmaceutical
$25M01 Dec 2006 Cambridge, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Kester Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 9
Average round size 2M
Rounds per year 0.60
Peak activity year 2006
Lead investments 6
Follow on index 0.11
Exits 3
Group Appearance index 0.11

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Xanthus Pharmaceuticals

Biopharma
Biotechnology
Medical
Pharmaceutical
$25M01 Dec 2006 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: